Comparative proteomics analysis of gastric cancer stem cells

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Morisaki, Tamami ^a   Yashiro, Masakazu ^a   Kakehashi, Anna ^a   Inagaki, Anna ^a   Kinoshita, Haruhito ^a   Fukuoka, Tatsunari ^a   Kasashima, Hiroaki ^a   Masuda, Go ^a   Sakurai, Katsunobu ^a   Kubo, Naoshi ^a   Muguruma, Kazuya ^a   Ohira, Masaichi ^a   Wanibuchi, Hideki ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOLASE A; CYTOKERATIN 18; DCTP PYROPHOSPHATASE 1; GOLGI GLYCOPROTEIN 1; HEAT SHOCK 70 KDA PROTEIN 4; HEAT SHOCK 70 KDA PROTEIN 9; RETINOBLASTOMA BINDING PROTEIN 6; TUMOR MARKER; UNCLASSIFIED DRUG; VACUOLAR PROTEIN SORTING 13 HOMOLOG A; CARRIER PROTEIN; DNA BINDING PROTEIN; RBBP6 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TANDEM MASS SPECTROMETRY; TUMOR INVASION; UNINDEXED SEQUENCE; UPREGULATION; CELL MOTION; COMPARATIVE STUDY; DEFICIENCY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; STOMACH NEOPLASMS; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PROGNOSIS; PROTEOMICS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 84917689681     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110736     Document Type: Article

References (56)

1. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344.
2. Yashiro M, Nishii T, Hasegawa T, Matsuzaki T, Morisaki T, et al. (2013) A cMet inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma. Br J Cancer 109: 2619-2628.
3. Nishii T, Yashiro M, Shinto O, Sawada T, Ohira M, et al. (2009) Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci 100: 1397-1402.
4. Glinsky GV, Berezovska O, Glinskii AB (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115: 1503-1521.
5. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
6. Takaishi S, Okumura T, Wang TC (2008) Gastric cancer stem cells. J Clin Oncol 26: 2876-2882
7. Stojnev S, Krstic M, Ristic-Petrovic A, Stefanovic V, Hattori T (2014) Gastric cancer stem cells: therapeutic targets. Gastric Cancer 17: 13-25.
8. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009) Gastric cancer. Lancet 374: 477-490.
9. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, et al. (2010) Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16: 45-55.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
11. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037
12. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
13. Chen S, Zhao H, Deng J, Liao P, Xu Z, et al. (2013) Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target. J Cell Biochem 114: 2795-2808.
14. Kakehashi A, Ishii N, Shibata T, Wei M, Okazaki E, et al. (2011) Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis. Toxicol Sci 119: 61-72.
15. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, et al. (1997) Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3: 1337-1345.
16. Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M (1996) Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis 14: 43-54.
17. Kato Y, Yashiro M, Noda S, Tendo M, Kashiwagi S, et al. (2010) Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma. Br J Cancer 102: 898-907.
18. Hasegawa T, Yashiro M, Nishii T, Matsuoka J, Fuyuhiro Y, et al. (2013) Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-beta signaling. Int J Cancer.
19. (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14: 101-112.
20. Chung K, Nishiyama N, Wanibuchi H, Yamano S, Hanada S, et al. (2012) AGR2 as a potential biomarker of human lung adenocarcinoma. Osaka City Med J 58: 13-24.
21. Kakehashi A, Hagiwara A, Imai N, Nagano K, Nishimaki F, et al. (2013) Mode of action of ethyl tertiary-butyl ether hepatotumorigenicity in the rat: evidence for a role of oxidative stress via activation of CAR, PXR and PPAR signaling pathways. Toxicol Appl Pharmacol 273: 390-400.
22. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, et al. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using aminereactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169.
23. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, et al. (2001) Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61: 889-895.
24. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, et al. (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: 1006-1020.
25. Wen L, Chen XZ, Yang K, Chen ZX, Zhang B, et al. (2013) Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review. PLoS One 8: e59154.
26. Liu J, Ma L, Xu J, Liu C, Zhang J, et al. (2013) Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties. Int J Oncol 42: 453-459.
27. Chibi M, Meyer M, Skepu A, DJ GR, Moolman-Smook JC, et al. (2008) RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1. J Mol Biol 384: 908-916.
28. Scott RE, White-Grindley E, Ruley HE, Chesler EJ, Williams RW (2005) P2P-R expression is genetically coregulated with components of the translation machinery and with PUM2, a translational repressor that associates with the P2P-R mRNA. J Cell Physiol 204: 99-105.
29. Pugh DJ, Ab E, Faro A, Lutya PT, Hoffmann E, et al. (2006) DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing and ubiquitinlike pathways. BMC Struct Biol 6: 1.
30. Simons A, Melamed-Bessudo C, Wolkowicz R, Sperling J, Sperling R, et al. (1997) PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb. Oncogene 14: 145-155.
31. Midgley CA, Lane DP (1997) p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15: 1179-1189.
32. Yoshitake Y, Nakatsura T, Monji M, Senju S, Matsuyoshi H, et al. (2004) Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis. Clin Cancer Res 10: 6437-6448.
33. Li L, Deng B, Xing G, Teng Y, Tian C, et al. (2007) PACT is a negative regulator of p53 and essential for cell growth and embryonic development. Proc Natl Acad Sci U S A 104: 7951-7956.
34. Kibriya MG, Jasmine F, Argos M, Andrulis IL, John EM, et al. (2009) A pilot genome-wide association study of early-onset breast cancer. Breast Cancer Res Treat 114: 463-477.
35. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, et al. (2001) Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 20: 7437-7446.
36. Yamaguchi F, Morrison RS, Gonatas NK, Takahashi H, Sugisaki Y, et al. (2003) Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas. Int J Oncol 22: 1045-1049.
37. An CH, Kim YR, Kim HS, Kim SS, Yoo NJ, et al. (2012) Frameshift mutations of vacuolar protein sorting genes in gastric and colorectal cancers with microsatellite instability. Hum Pathol 43: 40-47.
38. Thompson BJ, Mathieu J, Sung HH, Loeser E, Rorth P, et al. (2005) Tumor suppressor properties of the ESCRT-II complex component Vps25 in Drosophila. Dev Cell 9: 711-720.
39. Vaccari T, Bilder D (2005) The Drosophila tumor suppressor vps25 prevents nonautonomous overproliferation by regulating notch trafficking. Dev Cell 9: 687-698.
40. Zhang Y, Ye WY, Wang JQ, Wang SJ, Ji P, et al. (2013) dCTP pyrophosphohydrase exhibits nucleic accumulation in multiple carcinomas. Eur J Histochem 57: e29.
41. Yenari MA, Liu J, Zheng Z, Vexler ZS, Lee JE, et al. (2005) Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann N Y Acad Sci 1053: 74-83.
42. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, et al. (2006) Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5: 2592-2601.
43. Peng C, Yang P, Cui Y, He M, Liang L, et al. (2013) HSPA9 overexpression inhibits apoptin-induced apoptosis in the HepG2 cell line. Oncol Rep 29: 2431-2437.
44. Gestl EE, Anne Bottger S (2012) Cytoplasmic sequestration of the tumor suppressor p53 by a heat shock protein 70 family member, mortalin, in human colorectal adenocarcinoma cell lines. Biochem Biophys Res Commun 423: 411-416.
45. Zhong MA, Zhang H, Qi XY, Lu AG, You TG, et al. (2011) ShRNA-mediated gene silencing of heat shock protein 70 inhibits human colon cancer growth. Mol Med Rep 4: 805-810.
46. Wu CY, Lin CT, Wu MZ, Wu KJ (2011) Induction of HSPA4 and HSPA14 by NBS1 overexpression contributes to NBS1-induced in vitro metastatic and transformation activity. J Biomed Sci 18: 1.
47. Wei L, Liu TT, Wang HH, Hong HM, Yu AL, et al. (2011) Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelialmesenchymal transition and nuclear factor-kappaB. Breast Cancer Res 13: R101.
48. Nimmanapalli R, Gerbino E, Dalton WS, Gandhi V, Alsina M (2008) HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma. Br J Haematol 142: 551-561.
49. Giampieri R, Scartozzi M, Loretelli C, Piva F, Mandolesi A, et al. (2013) Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients. PLoS One 8: e72843.
50. Kajita E, Moriwaki J, Yatsuki H, Hori K, Miura K, et al. (2001) Quantitative expression studies of aldolase A, B and C genes in developing embryos and adult tissues of Xenopus laevis. Mech Dev 102: 283-287.
51. Shimizu T, Inoue KI, Hachiya H, Shibuya N, Shimoda M, et al. (2013) Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas. J Gastroenterol.
52. Du S, Guan Z, Hao L, Song Y, Wang L, et al. (2014) Fructose-bisphosphate aldolase a is a potential metastasis-associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration. PLoS One 9: e85804.
53. Fortier AM, Asselin E, Cadrin M (2013) Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation. J Biol Chem 288: 11555-11571.
54. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
55. Devarajan E, Song YH, Krishnappa S, Alt E (2012) Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissueresident stem cells. Int J Cancer 131: 1023-1031.
56. Kuramitsu Y, Baron B, Yoshino S, Zhang X, Tanaka T, et al. (2010) Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells. Anticancer Res 30: 4459-4465.